| Project/Area Number |
17590427
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Virology
|
|---|
| Research Institution | National Research Institute for Child Health and Development |
|---|
Principal Investigator |
IMADOME Ken-Ichi National Research Institute for Child Health and Development, Department of Infectious Diseases, Postdoctoral fellow, 母児感染研究部, 流動研究員 (70392488)
|
|---|
| Project Period (FY) |
2005 – 2006
|
| Project Status |
Completed (Fiscal Year 2006)
|
| Budget Amount *help |
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2006: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 2005: ¥2,500,000 (Direct Cost: ¥2,500,000)
|
|---|
| Keywords | EBV / CD40 / CD4OL / EBウイルス / CD40リガンド(CD40L) / CD40リガンド / 感染免疫学 |
|---|
| Research Abstract |
We investigated the role that CD40-CD40 ligand (CD40L) signaling plays in survival of Epstein-Barr virus (EBV)-infected T and NK cells. EBV-infected T and NK cell lines derived from patients with either chronic active EBV infection (CAEBV) or nasal T/NK cell lymphoma, as well as virus-infected peripheral T cells freshly isolated from a patient with CAEBV, were shown to express both CD40 and CD40L on their surface. Apoptosis of these cells was enhanced by blockade of CD40-CD40L signaling by a fusion protein of CD40 and immunoglobulin G (CD40Ig). Expression of CD40 was induced in human CD40L-positive Jurkat T cells after experimental EBV infection, and apoptosis of infected cells was enhanced by CD40Ig. These results suggest that CD40-CD40L signaling promotes survival of EBV-infected T and NK cells and, thus, plays an important role in the pathogenesis of T/NK lymphoproliferative disorders associated with the virus.
(1) Coexpression of CD40 and CD40L in EBV-infected T and NK cell lines derived from CAEBV and nasal T/NK cell lymphoma.
(2) Enhancement of apoptosis in EBV-infected T and NK cell lines by blockade of the interaction between CD40 and CD40L.
(3) Mediation by CD40 of protection from apoptosis.
(4) Mediation of a cell-survival signal by CD40 induced in Jurkat T cells, by EBV.
(5) Identification of EBV-infected T cells in peripheral blood from a patient with CAEBV and the role that CD40-CD40L signaling plays in their survival.
(6) XHIM-LCLs (established from X-linked Hyper IgM syndrome patients B cells) have the resistance for apoptosis less than normal-LCL.
|
